Biographical Sketch – Maria Rosaria Raspollini; MD, PhD
Maria Rosaria Raspollini graduated from the University of Florence, School of Medicine, Florence, Italy in 1994 summa cum laude, then trained in Pathology at the Institute of Pathology of the same University in 1998, and obtained the PhD degree in Human Oncological Pathology, at the University of Verona Medical School, Verona, Italy in 2005.
Since 2004, she is consultant pathologist at the Department of Histopathology and Molecular Diagnostics at the University Hospital Careggi of Florence, Italy. She is professor and tutor in Uropathology at the post-graduate School of Urology, University of Florence, Medical School. She served as teacher and tutor on Cytopathology and Gynaecological and Obstetrical Pathology at the post-graduate School of Anatomic Pathology, University of Florence Medical School and Gynaecological and Obstetrical Pathology, Diploma of Midwifery, University of Florence Medical School. From 2017 she is Counsil Member of European Society of Pathology (ESP). From 2017 she is Board Member of the EAU (European Association of Urology), Section of Uropathology (ESUP). From 2016 she is the official delegate of European Society of Pathology to the European Society of Gynaecological Oncology (ESGO). From 2014 she is a faculty member of the European Society Medical Oncology (ESMO) for the section Gynaecopathology.
From 2011 to 2013 she was Secretary/elected Chair of Gynaecological Pathology Working Group of the European Society of Pathology, and from 2013 to 2017 she was Chair of the Gynaecological Pathology Working Group of the European Society of Pathology. She was committed to the coordination of WG members, organizing training courses, promoting a series of cases collection among the WG members and coordinating a consensus group for the definition of Recommendations for the reporting of malignant ovarian surface epithelial/stromal tumours.
She actively worked to finalize the Memorandum of Understanding (MoU) between the European Society of Gynaecological Oncology and the European Society of Pathology. She promoted an active cooperation between the two Societies organizing specific joint sessions in the framework of the congresses of both Societies and common projects and guidelines on management of cervical carcinoma. Moreover, she is the co-chair of the project promoted by ESGO in cooperation with ESP and the European Society for Radiotherapy & Oncology (ESTRO) entitled ESGO Cervical Cancer Clinical Practice Guidelines – ESGO Cervix 2017. Since 2013 she is in the Scientific Committee of the European Congresses of Pathology for planning all gynaecopathology sessions and courses. She contributed also to organize the joint sessions with the Uropathology, Pediatric Pathology and Infectious diseases WGs in the framework of the European Congresses of Pathology. She organized national and international courses of Gynaecological and Urological pathology.
She was teacher and tutor on Renal tumors, Advance in Urological Oncology at the International School of Urology and Nephrology, Erice, Sicily, Italy. Her expertise and research activity have been focused on gynaecological and urological pathology, with competences in immunohistochemistry, cytogenetics and molecular biology. She is cooperating with many University centres in Europe and USA on different international projects. From 2010 to 2015 she served as chair of Quality and certification Standards of the University Hospital Careggi in Florence.
She has been invited speaker to many national and international courses and congresses, and has contributed to the scientific organization of national and international courses and meetings. She serves as referee for 25 peer-reviewed journals, and has published more than 150 scientific papers in peer reviewed journals, and chapters in textbooks in the field of gynaecological and genitourinary pathology. In addition she is co-editor of the following textbooks: “Gynecologic and Urologic Pathology. Similarities, Differences and Challenges” with Antonio Lopez-Beltran for Cambridge University Press, UK – 2017, “Pathology of the Prostate: An algorithmic approach” with Antonio Lopez-Beltran, Liang Cheng, and Rodolfo Montironi for Cambridge University Press, UK – 2017 and “Uropathology” in Encyclopedia of Pathology for Springer.
Antonio Lopez-Beltran M.D, Ph.D.
-Assistant Professor of Anatomic Pathology, Cordoba University Medical School, Cordoba, Spain 1986-2007
-Staff pathologist, Hospital Reina Sofia, Cordoba, Spain 1983-2007
-Full-Professor of Anatomic Pathology, Córdoba University Medical School, Cordoba, Spain 2007-2013
-Director of Anatomic Pathology, Althia Health Translational Research 2011-13
-Full-Professor of Anatomic Pathology (Part Time), Córdoba University Medical School, Cordoba, Spain 2013-current
-Director of Anatomic Pathology, Champalimaud Clinical Center, CCU, Lisbon, Portugal since July 2013-current
EDUCATION AND TRAINING
-Medical Degree, University of Seville, 1973-1979
-Residency in Anatomic Pathology, University of Seville 1979-1982
-PhD Experimental Pathology, University of Cordoba 1981-1984
-Anatomic Pathology, University College Hospital, London, UK, 1986 (6 months)
-Oncopathology, Roswell Park Cancer Institute, Buffalo, NY, 1987-1989 (2 years)
-Uropathology/Surgical Pathology, Mayo Clinic, Rochester, MN, 1995 (6 months)
-Molecular Oncology, Heidelberg University, Heidelberg, 2006 (1 month)
-Member of the USCAP and the European Society of Pathology (ESP)
-Founding Member of the International Society of Uropathology-ISUP
-Chairman, Eurpean Working Group on Urologic Pathology (ESP)
-Chairman, European Section of Uropathology (ESUP) (full section member of the European Association of Urology-EAU)
WHO CLASSIFICATION OF UROLOGIC TUMORS
-Member of the Experts Panel on Urologic Tumors who developed the 2004 WHO classification of Urologic Tumors (Book published 2004).
– Member of the Experts Panel attending the International Society of Urological Pathology (ISUP) Prostate Cancer Grading Panel Meeting. Chicago, Nov 1, 2014.
-Member of the Experts Panel on Urologic Tumors who developed the 2016 WHO classification of Urologic Tumors (Book published 2016).
Expert-scape Expertise in Urogenital Neoplasms Worldwide (2014/2015): Position 25 out of >75.217 experts.
PubMed 456 entries (Lopez-Beltran A; Beltran AL) (accessed April 16th, 2016)
10 most quoted publications:
(Index “h”=59 (April 2016, Google Academic)
- Epstein J I; M B Amin; V R Reuter; F K Mostofi; F Algaba; Allsbrook; A G Ayala; M J Becich; Lopez Beltran, Antonio; L Boccon-Gibod; D G Bostwick and the bladder consensus conference committee. A consensus classification of the urothelial lesions of the urinary bladder. American Journal of Surgical Pathology 22:1435-1448, 1998 (Citaciones 897)
- A Lopez–Beltran, M Scarpelli, R Montironi, Z Kirkali. WHO classification of the renal tumors of the adults – European Urology, Volume 49, Issue 5, May 2006, Pages 798–805 (Citaciones 541)
- Bostwick D G; Pacelli A; Lopez Beltran, Antonio. Molecular biology of prostatic intraepithelial neoplasia. Prostate 29:117-134, 1996 (Citaciones 224)
- Lopez Beltran, Antonio; A Pacelli; H J Rothenberg; P C Wollan; H Zincke; M L Blute; D G Bostwick. Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases. Journal of Urology 159:1497-1503, 1998 (Citaciones 238)
- Cheng L, XJ Yang, A lopez–beltran, et al Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients – Cancer, 2004, 101 :957-962. (Citaciones 225)
- A Lopez-Beltran, S Suzigan, R Montironi et al. Multilocular cystic renal cell carcinoma: a report of 45 cases of a kidney tumor of low malignant potential … – American journal of Clinical Pathology125:217-222, 2006 (Citaciones 167)
- L Cheng, M-T Sung, P Cossu-Rocca, TD Jones, GT MacLennan, J De Jong, A Lopez-Beltran, R Montironi, LHJ Looijenga. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. The Journal of Pathology Volume 211, Issue 1, pages 1–9, January 2007 (citaciones 187)
- A Lopez–Beltran, G Sauter, T Gasser, A Hartmann, BJ et al – World Health Organization classification of tumors, 2004. Infiltrating urothelial carcinoma (Citaciones 220)
- A Lopez–Beltran, R Montironi – Non-invasive urothelial neoplasms: according to the most recent WHO classification. European urology, Volume 46, Issue 2, August 2004, Pages 170–176. (Citaciones 157)
- A Lopez-Beltran, L Cheng. Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications- Human pathology, 2006 Nov;37(11):1371-88. (Citaciones 134)
DATE OF BIRTH: 6th April 1959
DEGREES AND POSTGRADUATE EDUCATION:
1977-1983: II nd University of Naples Medical School, Medical Degree, Summa cum Laude
1983-1987: II nd University of Naples Medical School,
Residency training program in Anatomic Pathology
1990-1994: University of Milan Medical School,
Residency training program in Neuropathology
Uropathology, soft tissue pathology,. More than 100 scientific publications in peer reviewed journals; more than 100 presentations at national and international congresses; 3 contributions to textbooks.
Editor Springer book: _Pathology of Testicular and Penile Neoplasms , (Heidelberg, 2016 in press).
Dr. Colecchia is Director of Uropathology Unit in the Department of Pathology at the National Cancer Institute in Milan and a Professor in the residency programme in Anatomical Pathology at the University Medical Centre of Varese, University of Insubria.
Previously, he was Director of Anatomical Pathology at Hospital Maggiore di Lodi.
AFFILIATION TO SCIENTIFIC SOCIETIES:
Since 1989: Italian Society of Anatomic Pathology and Cytology (SIAPEC)
Since 2011: International Society of Uropathology
Since 2012: European Society of Pathology (ESP)
He is Chairman of the Italian Group of Uropathology, a branch of the Italian Society of Pathology (Siapec), and a member of several scientific societies, including the European Society of Pathology (ESP) and the International Society of Uropathology (ISUP). and associate secretary of the ESUP (European Society of Uropathology). He is in the Editorial Board of Pathologica.
He is also a reviewer for a number of journals, including Human Pathology, Virchows Archiv, Histopathology, Analytical and Quantitative Cytology and Histology, Cancer Letter, International Urology and Nephrology, Tumori and others.
Sigurd Lax graduated from the University of Graz, School of Medicine in 1987 and subsequently trained in Pathology at the Institute of Pathology of the same university. From 1995 to 1997 he spent a research fellowship at the Department of Pathology of the Johns Hopkins Medical Institutions and Johns Hopkins University School of Medicine with Profs. Robert Kurman and Lora Hedrick Ellenson. In 1999 he received his venia docendi and in the same year a tenured faculty position as associate professor from the University of Graz. In 2002 he became head of a newly established department of pathology in an academic teaching hospital in Graz. In 2008 he was awarded with the title of full professor. He has published more than 150 articles in peer-reviewed journal and several book chapters. He has been president of the Austrian Society of Pathology/Austrian IAP division and German IAP division and associate editor of Virchows Archiv. During the last 15 years has given many lectures and seminars, among others in the German and Austrian IAP divisions and the European Society of Pathology.
Xavier Matias-Guiu obtained his PhD in 1987 in Barcelona. In 1991-92, XM was Research Fellow in Pathology at the New England Medical Centre/Tufts University in Boston, with Professors H Wolfe and R DeLellis, and the Massachusetts General Hospital with Professor Scully. From 1986 to 2002, XM worked with Professor Jaime Prat in Hospital Sant Pau, Barcelona. Currently, he combines the position of Chairman of Pathology at Hospital Universitari Bellvitge in Barcelona, Hospital Universitari Arnau de Vilanova in Lleida, and the direction of a research group as Professor of Pathology at University of Lleida, with especial focus in integrating molecular features of gynecological cancers in the appropriate microscopic context. He has participated in the panel for defining the WHO classification of the tumors of the Female Genital Tract (Pathology and Genetics).
I am a consultant Histopathologist in Royal Group of Hospitals Trust, Belfast and an
Honorary Professor in Gynaecological Pathology of Queen’s University of Belfast. I have published over 400 papers in peer reviewed journals, including original publications and many invited editorials and reviews. I am on the Editorial Board of several major pathology journals and associate editor of Histopathology. I am currently President of International Society of Gynecological Pathologists and was previously secretary of this society. Previously I was President of the British Association of Gynaecological Pathologists. I have an extremely busy referral practice and have been invited to lecture at numerous national and international meetings. I have authored or coauthored the various Royal College of Pathologists datasets in United Kingdom on reporting of gynaecological malignancies and have chaired the ICCR (International Collaboration on Cancer Reporting) panels developing international guidelines for reporting endometrial and ovarian carcinomas. I am currently chairing the ICCR panel developing the cervical cancer dataset. I have been part of the last 2 WHO groups formulating the classification of Tumours of the Female Genital Tract. My main diagnostic interests are gynaecological malignancies and the uses of immunohistochemistry in gynaecological pathology.
Rodolfo Montironi, MD and IFCAP, obtained his medical degree at the Medical School of the University of Ancona, Italy in 1976, the board certificate in pathology and laboratory medicine at the University of Parma, Italy, in 1979, and the board certificate in clinical oncology at the University of Ancona in 1982. He received his advanced training in pathology in several British institutions under the supervision of world leaders in pathology, in particular at Hammersmith Hospital, London, UK, with Dr. John G. Azzopardi in 1979. He is International Fellow of the College of American Pathologists. He is Professor of Pathology at the Medical School of the Polytechnic University of the Marche Region, and, Director of the Uropathology Program, United Hospitals, Ancona, Italy. He is a Past President of the International Society of Urological Pathology. He is the Chairman of the ESUP (EAU Section of Uropathology). He is a member of different international societies of pathology and of urology, including the European Society of Pathology and European Association of Urology. Dr Montironi’s work is centered in genitourinary tumor pathology. He is an author or coauthor of more than 700 publications in peer-reviewed international journals and of more than 30 chapters in books in the field of genitourinary tumor pathology. He has been a regular invited speaker at all major national and international pathology meetings. He organized and co-organized several international courses on genitourinary tumor pathology. Dr Montironi serves on the editorial boards of several international pathology and urology journals, including European Urology (Consulting Editor).
Biosketch Holger Moch
Holger Moch, MD is Professor of Pathology at the University Zurich and Chairman of the Institute for Pathology and Molecular Pathology, University Hospital Zurich, Switzerland since 2004. Holger Moch is board certified in Pathology and in Molecular Pathology. He graduated from Humboldt University Berlin (Charité), Germany and received his MD in 1988. Following graduation, he was a resident at the Institute for Pathology, Charité Berlin and at the Institute for Pathology, University Basel, Switzerland. He was a research fellow in the Division of Molecular Cytometry, Department of Laboratory Medicine, University of California San Francisco; USA and a visiting fellow at Harvard Medical School, Department of Pathology, Massachusetts General Hospital Boston, Massachusetts, USA. In 2001, he was promoted to Associate Professor of Pathology (Titularprofessor) of the University Basel, Switzerland.
Dr. Moch developed a robust translational research program to understand the molecular background of urogenital tumors. In 2014, he has founded the joint Competence Center for Personalized Medicine (CC-PM) at the University Zurich and the Swiss Federal Institute of Technology in Zurich (ETHZ) and serves as CC-PM Co-Director. His work is described in more than 500 peer-reviewed papers (H-Index 77) and he edited the 2016 WHO “blue book” World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs. He is a member of the German National Academy of Science Leopoldina and the Swiss Academy of Medical Sciences. Holger Moch is president-elect of the European Society of Pathology (ESP).